Xiaorong Ye1, Yue Yu2, Xiaohu Zheng3,4,5

  • 1Department of Gastroenterology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui Province, People's Republic of China.

概括

胰腺癌免疫疗法面临着由于瘤微环境和有限的免疫性而面临的挑战. 研究重点是克服耐药性,以提高这种困难疾病的治疗效率.